LN Peptides
Retatrutide
Finnrick tested 2 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from LN Peptides between 5 Dec 2024 and 17 Nov 2025. Test scores average over 6, no score below 5, and at least 2 tests warrant a tentative Finnrick Rating of B (Good).
Finnrick Rating™
Tentative Rating
LN Peptides
Retatrutide
Tested 2 Samples
Last test 17 Nov 2025
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from LN Peptides
Samples are tested in commercial labs
Tests Count
2
Scores
AVGMINMAX
Last
17 Nov 2025
First
5 Dec 2024
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 17 Nov 2025 | View | 40mg | 37.7mg | -5.8% | 99.68% | (no batch ID) | White Label / Silver Crimp / Clear Pink Cap | Lab E | Public | |
| 5 Dec 2024 | View | 50mg | 42.1mg | -15.8% | 99.70% | (no batch ID) | No Label / Silver Crimp / Clear Pink Cap | Lab G | Public | |